ÂÜÀòÂÒÂ×

Nick DeHaan is a seasoned professional in business development with extensive experience in the biotechnology and healthcare sectors. Currently serving as the Director of Business Development at Cytokinetics, Nick focuses on transactions related to early-stage medicines and enabling technologies. Previous roles include Vice President and Head of Partnerships at Celeris Therapeutics, where leadership in business development for AI-based small-molecule degraders was key, and Partnering Executive at Atomwise, managing a notable academic partnering program. Earlier experience includes a senior role at the University of Michigan Medical School, where Nick implemented early-stage commercialization programs, as well as founding multiple ventures in social media, consulting, and technology commercialization. Nick holds a Master of Entrepreneurship and a Bachelor of Science in Biochemistry from the University of Michigan.